US Stock MarketDetailed Quotes

ANTX AN2 Therapeutics

Watchlist
  • 2.560
  • +0.020+0.79%
Close May 3 16:00 ET
  • 2.560
  • 0.0000.00%
Post 16:02 ET
76.36MMarket Cap-934P/E (TTM)

About AN2 Therapeutics Company

AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley and is headquartered in Menlo Park, CA.

Company Profile

SymbolANTX
Company NameAN2 Therapeutics
Listing DateMar 25, 2022
Issue Price15.00
Founded2017
CEOMr. Eric Easom
MarketNASDAQ
Employees41
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1800 El Camino Real,Suite D
CityMenlo Park
ProvinceCalifornia
CountryUnited States of America
Zip Code94027
Phone1-650-331-9090
Websitehttp://www.an2therapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Eric Easom
  • Chief Executive Officer, President and Director
  • 3.34M
  • Dr. Paul Eckburg, M.D.
  • Chief Medical Officer
  • 1.45M
  • Lucy O. Day
  • Chief Financial Officer and Principal Accounting Officer
  • 1.52M
  • Kevin Krause
  • Chief Strategy Officer
  • --
  • Joshua M. Eizen, J.D.
  • Chief Legal Officer and Corporate Secretary
  • --
  • Dr. Sanjay Chanda, PhD
  • Chief Development Officer
  • --
  • Joseph S. Zakrzewski
  • Chairman of the Board
  • 179.64K
  • Margaret M. FitzPatrick
  • Independent Director
  • 142.14K
  • Stephanie Wong
  • Independent Director
  • 157.14K
  • Dr. Rob Readnour, PhD
  • Independent Director
  • 146.14K
  • Dr. Melvin K. Spigelman,M.D.
  • Independent Director
  • 145.64K
  • Patricia Martin
  • Independent Director
  • 153.14K
  • Kabeer Aziz
  • Independent Director
  • 145.64K
  • Gilbert Lynn Marks
  • Independent Director
  • 145.64K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg